FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Genzyme related Press Releases

Genzyme Corporation Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease

Posted March 19, 2009

Genzyme Corporation Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease March 19, 2009 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ)

... Read more...

Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ)

Posted January 13, 2009

Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ) January 13, 2009 NEW YORK--(BUSINESS WIRE)--Shareholders of Genzyme Biosurgery

... Read more...

FDA Approves Genzyme Corporation (GENZ)'s Mozobil

Posted December 16, 2008

FDA Approves Genzyme Corporation (GENZ)'s Mozobil CAMBRIDGE, Mass., Dec 15, 2008 (BUSINESS WIRE) -- Genzyme Corporation announced today that the U.S. Food and Drug Administration has granted

... Read more...

Genzyme Seeks U.S. Approval for Clolar® to Treat Adult AML

Posted November 24, 2008

Genzyme Seeks U.S. Approval for Clolar® to Treat Adult AML Indication Would Address Significant Unmet Medical Need and Expand Product Use CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation

... Read more...

Genzyme Reports Strong Third-Quarter Sales and Earnings Growth

Posted October 22, 2008

Genzyme Reports Strong Third-Quarter Sales and Earnings Growth Company Expects 2009 Non-GAAP EPS of Approximately $4.70 October 22, 2008--CAMBRIDGE, Mass.--(

... Read more...

FDA Advisory Panel to Discuss Genzyme's Myozyme BLA on Tuesday

Posted October 17, 2008

FDA Advisory Panel to Discuss Genzyme's Myozyme BLA on Tuesday Meeting Will Focus on Clinical Data Supporting 2000 L Process CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 17, 2008--Genzyme Corporation... Read more...

Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease

Posted October 15, 2008

Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease CAMBRIDGE, Mass.--(BUSINESS WIRE)--October 15, 2008--Genzyme Corporation (Nasdaq:... Read more...

Science survey ranks top biopharma employers

Posted October 10, 2008

Science survey ranks top biopharma employers Science's annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to... Read more...

Genzyme Corporation (GENZ) Marks Grand Opening of $125 Million Science Center; Among the First Research Laboratories to Earn Gol

Posted September 22, 2008

Genzyme Corporation (GENZ) Marks Grand Opening of $125 Million Science Center; Among the First Research Laboratories to Earn Gold LEED Rating CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp.... Read more...

Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discove

Posted August 26, 2008

Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria Brings complementary capabilities in... Read more...